Table 3

Intraoperative data of patients
Parameter
Procedural success, n (%) 11 (100)
Conversion to surgical AVR, n (%) 0 (0)
Intraprocedural circulatory depression, n (%) 1 (9.1)
Catecholamine therapy, n (%) 1 (9.1)
Resuscitation, n (%) 1 (9.1)
Defibrillation, n (%) 1 (9.1)
Vascular access site complication requiring surgery, n (%) 1 (9.1)
Contrast agent (ml) 120.9 ± 44.7
Procedure time (min) 110.3 ± 29.5
Fluoroscopy time (min) 16.0 ± 6.8
CoreValve size (mm)
 26 9 (81.8)
 29 2 (18.2)
Pre TAVI valvuloplasty, n (%) 11 (100)
Post TAVI valvuloplasty, n (%) 5 (45.5)
Number of inflations after TAVI (n) 1.2 ± 0.6
Balloon diameter (mm) 20.6 ± 1.8
Balloon length (mm) 62.7 ± 16.8
Valve embolization, n (%) 2 (18.2)
Post TAVI aortic valve mean gradient 5.3 ± 4.1
Angiographic aortic insufficiency (grade) 0.9 ± 0.45
ICU stay (days) 3.36 ± 1.9
Hospital stay (days) 18.5 ± 5.4

Akin et al.

Akin et al. BMC Cardiovascular Disorders 2012 12:80   doi:10.1186/1471-2261-12-80

Open Data